Oncology & Cancer

Study validates therapy for aggressive bladder cancer

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...

Oncology & Cancer

Can you keep your bladder after bladder cancer strikes?

After being diagnosed with bladder cancer, some patients face an almost impossible decision—have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact.

Medical research

Study sheds new light on the growth of bladder cancer

New Curtin University-led research has discovered that using drugs to target a pathway in the body that causes cancerous cells to spread aggressively may help to reduce the severity of bladder cancer.

page 2 from 3